High-dose semaglutide and tirzepatide have produced even greater results in non-diabetic populations, often achieving a 10-15% reduction in baseline body weight
Although there have been significant studies conducted on the pathophysiology and etiology of hypertension, it is still the case that over 95% of individuals with hypertension do not have a known cause
Frequent dose-skipping requires consultation with a healthcare provider, since this pattern may necessitate adjusting the treatment plan
As more and more data becomes available, the cost benefit analysis of these drugs will become impossible to ignore for health insurance companies
Yet, as Makad underscored, weight management treatment is supposed to sit alongside changes in nutrition and physical activity, as part of a broader management strategy rather than a standalone fix
When we use nutrition to increase GLP-1 naturally, we arent just suppressing an urge, but also supporting the biological pathways that manage hunger